These effects appear to be due to increased secretion of intestinal hormones of Pyy, GLP-2 and GLP-1 (158,162), reduced appetite peptide of avergerlin (177, 181) and endotoxemia reduction by improving the function of the mucous membrane and reducing the level of inflammatory markers (180, 181). This evidence concerns the gene GCG and serum lipopolysaccharide activity.